148 related articles for article (PubMed ID: 23194125)
1. Nurse-led flexible cystoscopy in Australia: initial experience and early results.
Sapre N; Bugeja P; Hayes E; Corcoran NM; Costello A; Anderson PD
BJU Int; 2012 Dec; 110 Suppl 4():46-50. PubMed ID: 23194125
[TBL] [Abstract][Full Text] [Related]
2. Re: Nurse-led flexible cystoscopy in Australia: initial experience and early results.
Penson DF
J Urol; 2013 Sep; 190(3):977-8. PubMed ID: 23931212
[No Abstract] [Full Text] [Related]
3. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.
Witjes JA; Moonen PM; van der Heijden AG
Eur Urol; 2005 Mar; 47(3):319-22. PubMed ID: 15716194
[TBL] [Abstract][Full Text] [Related]
5. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
Loidl W; Schmidbauer J; Susani M; Marberger M
Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
[TBL] [Abstract][Full Text] [Related]
6. [Follow up of urinary bladder cancer--a task for the urology nurse?].
Fagerberg M; Nostell PO
Lakartidningen; 2005 Jul 25-Aug 7; 102(30-31):2149-50. PubMed ID: 16111105
[TBL] [Abstract][Full Text] [Related]
7. Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin.
Ray ER; Chatterton K; Khan MS; Chandra A; Thomas K; Dasgupta P; O'Brien TS
BJU Int; 2010 Mar; 105(6):789-94. PubMed ID: 19832725
[TBL] [Abstract][Full Text] [Related]
8. Improving a nurse-led flexible cystoscopy service through audit.
Kilburn K
Prof Nurse; 2002 Jun; 17(10):601-4. PubMed ID: 12087708
[TBL] [Abstract][Full Text] [Related]
9. Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
Lightfoot AJ; Rosevear HM; Nepple KG; O'Donnell MA
Int J Urol; 2012 Nov; 19(11):988-93. PubMed ID: 22762480
[TBL] [Abstract][Full Text] [Related]
10. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
11. Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.
Kamat AM; Karam JA; Grossman HB; Kader AK; Munsell M; Dinney CP
BJU Int; 2011 Oct; 108(7):1119-23. PubMed ID: 21426474
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
13. Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
Holmäng S; Ströck V
Eur Urol; 2012 Mar; 61(3):503-7. PubMed ID: 22119022
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of a nurse-led cystoscopy surveillance service.
Taylor J
Prof Nurse; 2003 Jun; 18(10):580-3. PubMed ID: 12808860
[TBL] [Abstract][Full Text] [Related]
15. Cytologic and cystoscopic predictors of recurrence and progression in patients with low-grade urothelial carcinoma.
Jackson J; Barkan GA; Kapur U; Wojcik EM
Cancer Cytopathol; 2013 Jul; 121(7):398-402. PubMed ID: 23364860
[TBL] [Abstract][Full Text] [Related]
16. The process and outcomes of a nurse-led colorectal cancer follow-up clinic.
McFarlane K; Dixon L; Wakeman CJ; Robertson GM; Eglinton TW; Frizelle FA
Colorectal Dis; 2012 May; 14(5):e245-9. PubMed ID: 22182050
[TBL] [Abstract][Full Text] [Related]
17. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence cystoscopy: is flexible scope as effective as rigid?
Zlotta A
Eur Urol; 2005 Mar; 47(3):318. PubMed ID: 15716193
[No Abstract] [Full Text] [Related]
19. [Narrowband fibrocystoscopy in diagnosis of bladder cancer].
Martov AG; Maksimov VA; Ergakov DV; Adronov AS
Urologiia; 2009; (5):54-9. PubMed ID: 20213913
[TBL] [Abstract][Full Text] [Related]
20. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
